Effect of a Chikungunya Virus–Like Particle Vaccine on Safety and Tolerability Outcomes-Reference-Cited by-同舟云学术

Effect of a Chikungunya Virus–Like Particle Vaccine on Safety and Tolerability Outcomes

Published:2020-04-14 Issue:14 Volume:323 Page:1369
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Chen Grace L.¹,Coates Emily E.¹,Plummer Sarah H.¹,Carter Cristina A.¹,Berkowitz Nina¹,Conan-Cibotti Michelle¹,Cox Josephine H.¹,Beck Allison¹,O’Callahan Mark¹,Andrews Charla¹,Gordon Ingelise J.¹,Larkin Brenda¹,Lampley Rebecca¹,Kaltovich Florence¹,Gall Jason¹,Carlton Kevin¹,Mendy Jason²,Haney Doug²,May Jeanine³,Bray Amy³,Bailer Robert T.¹,Dowd Kimberly A.⁴,Brockett Brittanie⁴,Gordon David⁴,Koup Richard A.¹,Schwartz Richard¹,Mascola John R.¹,Graham Barney S.¹,Pierson Theodore C.⁴,Donastorg Yeycy⁵,Rosario Nicolas⁶,Pape Jean William⁷,Hoen Bruno⁸,Cabié André⁹,Diaz Clemente¹⁰¹¹,Ledgerwood Julie E.¹,

Affiliation:

1. Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

2. Emergent BioSolutions, San Diego, California

3. The Emmes Company, Rockville, Maryland

4. Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

5. Instituto Dermatologico y Cirugia de Piel (IDCP), Dominican Republic

6. San Juan Hospital, Puerto Rico

7. The Haitian Group for the Study of Kaposi’s Sarcoma and Opportunistic Infections (Centres GHESKIO), Haiti

8. INSERM Centre d’Investigation Clinique (CIC) 1424, Centre Hospitalier Universitaire (CHU) de la Guadeloupe, France

9. INSERM Centre d’Investigation Clinique (CIC) 1424, Centre Hospitalier Universitaire (CHU) de Martinique, France

10. PR Clinical and Translational Research Consortium (PRCTRC), Puerto Rico

11. University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2764456/jama_chen_2020_oi_200023.pdf

Reference20 articles.

1. A virus-like particle vaccine elicits broad neutralizing antibody responses in humans to all chikungunya virus genotypes.;Goo;J Infect Dis,2016

2. Chikungunya in the Americas.;Leparc-Goffart;Lancet,2014

3. Epidemiology of chikungunya in the Americas.;Yactayo;J Infect Dis,2016

4. Biology and pathogenesis of chikungunya virus.;Schwartz;Nat Rev Microbiol,2010

5. Chikungunya virus-associated disease.;Hua;Curr Rheumatol Rep,2017

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonreciprocity in CHIKV and MAYV Vaccine-Elicited Protection;Vaccines;2024-08-27

2. Immunogenicity and Safety of Chikungunya Vaccines: A Systematic Review and Meta-Analysis;Vaccines;2024-08-27

3. Chikungunya virus vaccine: a decade of progress solving epidemiological dilemma, emerging concepts, and immunological interventions;Frontiers in Microbiology;2024-07-22

4. Nanocarriers of antigen proteins for vaccine delivery;International Journal of Pharmaceutics;2024-06

5. Chikungunya e Dengue: tutta colpa di una zanzara. Epidemiologia, clinica e prevenzione vaccinale;Medico e Bambino Pagine elettroniche;2024-04-24